SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ZIM Integrated Shipping Services Ltd. engages in the provision of shipping and logistics services. It offers shipping solutions, including the transportation of out-of-gauge cargo, refrigerated cargo, and dangerous and hazardous cargo. The company was founded on June 7, 1945 and is headquartered in Haifa, Israel.

Zim Integrated Shipping Services Ltd

ZIM is trending due to Hapag-Lloyd's agreed acquisition at $35 per share, sparking widespread community discussion around potential short squeezes and whether the Israeli government will approve the deal amid national security concerns and a long closing timeline.

PepeCoin is a meme token based on the character Pepe the Frog. Initially launched in March 2016 on its own blockchain, it later migrated to Ethereum. PepeCoin is recognized as the original Pepe currency due to its long history.   The project aims to provide a variety of use cases, transforming PepeCoin into a memecoin with utility.  The community is primarily focused on creating a fun atmosphere, actively engaging in various events to enhance the token's growth and visibility. Additionally, PepeCoin is developing a game that will serve as an interactive social Web 3.0 video game platform, further expanding its ecosystem and fostering interaction among users.

PepeCoin

PepeCoin is trending as its community vigorously debates its distinction as the original Pepe token, highlighting its robust utility through projects like BasedAI and Kekspace, and its deflationary, mineable design. The conversation centers on its perceived undervaluation and growing recognition as a foundational project rather than just another meme coin, drawing a sharp contrast with the widely traded $PEPE.

Fiverr International Ltd. develops an e-commerce platform that allows people to buy and sell digital services. It operates through the following geographical segments: U.S., Europe, Asia Pacific, Rest of the World and Israel. The firm offers digital marketing, graphics and design, video and animation, writing and translation, and music and audio. The company was founded by Micha Kaufman and Shai Wininger in 2009 and is headquartered in Tel Aviv, Israel.

Fiverr International Ltd

Fiverr is trending amidst robust debate on whether recent strong earnings, an expanded share repurchase program, and strategic restructuring firmly position it as a deeply undervalued leader adapting to AI. While bulls cite its cash-rich balance sheet and positive free cash flow, bears remain concerned that AI will ultimately disrupt its gig economy model.

Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bear 3X Shares

Direxion Daily S&P Biotech Bear 3X Shares

Direxion Daily S&P Biotech Bear 3X Shares (LABD) is trending as frustrated investors grapple with significant losses, questioning market rationality while the underlying S&P Biotech Index (XBI) continues an unexpectedly strong rally, defying bearish sentiment and prompting intense debate over an imminent correction or continued sector strength.

Savara, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of novel therapies for the treatment of serious or life-threatening rare respiratory diseases. Its program includes molgramostim, which is an inhaled formulation of recombinant human GM-CSF and being developed for the treatment of autoimmune pulmonary alveolar proteinosis. The company was founded in December 1995 and is headquartered in Langhorne, PA.

Savara Inc

Savara Inc. is trending due to overwhelmingly positive Phase 3 trial results for Molgramostim, its lead candidate for autoimmune PAP, a rare lung disease with no approved therapies. This success has sparked significant investor optimism for potential FDA approval and market opportunity, along with a flurry of analyst upgrades and active speculation about a potential acquisition.

Sui is an innovative layer-1 blockchain platform crafted to meet the demands of global adoption, providing a secure, robust, and scalable development environment. Rooted in a unique object-centric data model and fortified by the trusted Move programming language, Sui is engineered to tackle the inefficiencies found in current blockchain frameworks.  In addition to its solid technical underpinnings, Sui places a strong emphasis on user experience, aiming to remove common barriers encountered in blockchain interactions. Through groundbreaking features such as zkLogin, sponsored transactions, and programmable transaction blocks, Sui sets a new standard for user accessibility and friendliness within Web3 applications.  Unique elements of Sui Sui’s innovative architecture ensures swift transactions with stable fees and high throughput through horizontal scaling. Its object-oriented design offers deep composability for developers, enabling tailored object types with network-wide compatibility. This revolutionizes asset and protocol collaboration, fostering product innovation.  The platform's object-oriented approach dramatically improves transaction processing, enabling parallel execution and faster completion times. Additionally, unique consensus requirements expedite transaction finalization while maintaining stability. Sui prioritizes overcoming Web3 adoption barriers, offering native tools like zkLogin and sponsored transactions for wallet onboarding and fee management.  Move integration into Sui's data model combines innovation with security, mitigating common exploits found in smart contract languages. This empowers developers and users with a secure and intuitive platform, accelerating the evolution of Web3 applications.  About the Sui token The SUI token serves four primary functions within the Sui ecosystem: Proof-of-stake participation - Sui implements a delegated proof-of-stake mechanism, rewarding honest behavior by validators and SUI token holders who stake with them. Gas fee payments - SUI tokens cover gas fees for executing transactions and storing data onchain. Application utility - SUI is a versatile asset, integral to various applications within Sui’s ecosystem, including decentralized exchanges, lending platforms, gaming, and more. Governance - The SUI token empowers holders to participate in on-chain voting on significant matters like protocol upgrades and platform changes, shaping the future of Sui.  Additionally, the Sui storage fund ensures fair compensation for validators by distributing stake rewards over time and covering storage costs for previously stored on-chain data. This tokenomic strategy promotes indefinite data storage while maintaining fair compensation for validators, fostering long-term sustainability.

SUI is trending as the community champions its advanced blockchain technology and superior efficiency, often positioning it as the "next Solana" due to its robust performance and minimal network issues. Investors are actively accumulating the asset, anticipating a potential altcoin season and the impact of upcoming SUI ETFs, which are driving strong long-term bullish sentiment.

BlockDAG

BlockDAG is trending amid widespread community frustration and escalating concerns over its prolonged presale, confusing launch timelines, and persistent reports of users unable to claim their purchased tokens, fueling rampant speculation about the project's legitimacy and fears of a potential scam.

ETF Opportunities Trust - T-Rex 2X Inverse MSTR Daily Target ETF

T-Rex 2X Inverse MSTR Daily Target ETF

MSTZ is seeing significant trading volume as the community actively leverages its inverse relationship to MicroStrategy, betting against MSTR's Bitcoin holdings amidst ongoing crypto market uncertainty and a strong belief that MSTR's valuation is vulnerable.

Cleveland-Cliffs, Inc. is a flat-rolled steel company, which engages in provision of iron ore pellets to the North American steel industry. It focuses on the production of metallic and coke, iron making, steelmaking, rolling and finishing, and downstream tubular components, stamping, and tooling. The company was founded in 1847 and is headquartered in Cleveland, OH.

Cleveland-Cliffs Inc

Cleveland-Cliffs (CLF) is a hot topic as investors weigh a mixed earnings report and news of the CEO's share sale, igniting concerns over management and the company's debt load. However, a segment of the community is buying the dip, optimistic about the 2026 outlook with anticipated cost reductions, increased steel shipments, and ongoing strategic partnership talks with POSCO.

Chewy, Inc. operates as an online retailer of pet food and other pet-related products and services. It supplies pet medications, food, treats and other pet-health products and services for dogs, cats, fish, birds, small pets, horses, and reptiles. It has a portfolio of pet healthcare offerings that includes Chewy Pharmacy, Connect with a Vet, and CarePlus, an exclusive suite of pet-first insurance and wellness plans. The company was founded by Ryan Cohen and Michael Day in September 2011 and is headquartered in Plantation, FL.

Chewy Inc - Ordinary Shares - Class A

Chewy Inc

Chewy is in a persistent downtrend, hitting new 52-week lows amid leadership changes and disappointing guidance, leaving many investors frustrated about the stock's performance. However, a segment of the community views the deep valuation and institutional buying as a strong opportunity, confident in the company's solid fundamentals and loyal customer base.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Equities Analysts Set Expectations for CRDL FY2025 Earnings

Cardiol Therapeutics Inc. (NASDAQ:CRDL - Free Report) - Research analysts at Brookline Cap M issued their FY2025 EPS estimates for shares of Cardiol Therapeutics in a note issued to investors on...

Cardiol Therapeutics (NASDAQ:CRDL) Stock Rating Upgraded by Brookline Cap M

Brookline Cap M upgraded shares of Cardiol Therapeutics to a "strong-buy" rating in a research report on Tuesday...

Analysts Offer Predictions for CRDL FY2025 Earnings

Cardiol Therapeutics Inc. (NASDAQ:CRDL - Free Report) - Stock analysts at Brookline Capital Management issued their FY2025 earnings per share estimates for Cardiol Therapeutics in a research report...

Cardiol Therapeutics (TSE:CRDL) Shares Down 7.1% - Time to Sell?

Cardiol Therapeutics (TSE:CRDL) Shares Down 7.1% - Here's What Happened...

Cardiol Therapeutics (TSE:CRDL) Shares Down 7.1% - What's Next?

Cardiol Therapeutics (TSE:CRDL) Trading Down 7.1% - What's Next...

Cardiol Therapeutics (NASDAQ:CRDL) Raised to Strong-Buy at Brookline Capital Management

Brookline Capital Management upgraded shares of Cardiol Therapeutics to a "strong-buy" rating in a research note on Tuesday...

Cardiol Therapeutics (TSE:CRDL) Stock Price Up 1.5% - Still a Buy?

Cardiol Therapeutics (TSE:CRDL) Trading 1.5% Higher - What's Next...

Cardiol Therapeutics (TSE:CRDL) Stock Price Down 0.7% - Here's Why

Cardiol Therapeutics (TSE:CRDL) Trading Down 0.7% - Here's What Happened...

Cardiol Therapeutics Inc. (NASDAQ:CRDL) Given Average Recommendation of "Buy" by Brokerages

Shares of Cardiol Therapeutics Inc. (NASDAQ:CRDL - Get Free Report) have received a consensus rating of "Buy" from the five research firms that are covering the stock, MarketBeat reports. One...

Cardiol Therapeutics (NASDAQ:CRDL) Receives "Buy" Rating from HC Wainwright

HC Wainwright reiterated a "buy" rating and set a $9.00 price objective on shares of Cardiol Therapeutics in a report on Monday...

Cardiol Therapeutics, Inc. is a clinical-stage life sciences company focused on the research and clinical of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. Its lead product candidate, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation that is being clinically developed for use in heart diseases. The firm is conducting clinical studies to evaluate the efficacy and safety of CardiolRx in diseases affecting the heart: a Phase II multi-national, randomized, double-blind, placebo-controlled trial (the ARCHER trial) in acute myocarditis; and a Phase II multi-center open-label pilot study in recurrent pericarditis. It is also involved in developing a novel subcutaneously administered drug formulation of cannabidiol intended for use in heart failure. The company was founded by David Elsley, Eldon Smith, and Anthony Bolton on January 19, 2017 and is headquartered in Oakville, Canada.

Cardiol Therapeutics Inc - Ordinary Shares - Class A

3%+ above current levels

Up 0–3%

Flat to down 3%

Down 3%+

The Nasdaq 100 continues to hinge on mega-cap tech and AI strength. With rate expectations shifting and valuations stretched, even a 3% move could signal a bigger trend. Is momentum building, or fading?

Current Price	$1.04
Prev Close	$1.02
Open	$0.99
Dividend Yield	0.00%
50-Day Moving Average	$1.01
Beta	1.23
Avg. Volume	326,599.45
PE Ratio	-3.47

52-Week High	$1.59
52-Week Low	$0.7709
Market Capitalization	$104M
EPS (Annual)	-$0.3741
Price to Book	13.24
Revenue Per Employee	$0.00

CRDL
Cardiol Therapeutics Inc - Ordinary Shares - Class A

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest CRDL News

CRDLCardiol Therapeutics Inc - Ordinary Shares - Class A